ASPEN Clinical Trial

 ASPEN, a new investigator-initiated study being led by Duke University, is now enrolling patients with metastatic renal-cell carcinoma with non-clear cell histology. Click here for more information.Listen to the podcast featuring lead investigator Andrew J. Armstrong, MD ScM, Assistant Professor of Medicine and Surgery at Duke Comprehensive Cancer Center, as he describes this trial. Patients interested should refer toclinicaltrials.govfor the nearest open site.01/25/2011
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news